Federal Healthcare Fraud Defense Attorney | DOJ 2026 Enforcement Priorities

The government is not scaling back its healthcare fraud enforcement in 2026. It is accelerating — with better technology, more funding, and a new organizational structure built specifically to pursue you.

In June 2025, DOJ announced the largest National Health Care Fraud Takedown in its history: 324 defendants charged, including 96 licensed medical professionals, for alleged fraud schemes totaling more than $14.6 billion in intended loss — more than double the prior record of $6 billion. That same fiscal year, False Claims Act settlements and judgments exceeded $6.8 billion — the highest single-year recovery in the statute’s modern history. Whistleblowers filed 1,297 qui tam lawsuits. Again, a record.

Most of the physicians and healthcare executives caught in these investigations did not wake up one morning and decide to commit fraud. They expanded into telemedicine. They signed medical directorship agreements. They made billing decisions under time pressure, without adequate legal review. Now they face federal indictments, exclusion from federal healthcare programs, and — in serious cases — prison sentences measured in years.

This article explains what DOJ is targeting in 2026, what the early warning signs look like before you know you are a target, and why early defense is the only rational strategic response. Whether you are a physician, a practice owner, a healthcare executive, a telemedicine operator, or a government health contractor — and whether you are looking for a federal healthcare fraud defense attorney now or trying to avoid needing one — this is what you need to understand before a subpoena arrives.

DOJ’s 2026 Healthcare Fraud Enforcement Machine

The numbers are not talking points. They reflect a structural shift in how aggressively the federal government pursues healthcare fraud — and how effectively.

The 2025 National Health Care Fraud Takedown produced criminal charges against 324 defendants across 50 federal districts and 12 State Attorneys General’s Offices for alleged fraud involving over $14.6 billion in intended loss. Among those charged: 96 doctors, nurse practitioners, pharmacists, and other licensed medical professionals. Civil charges against 20 additional defendants and civil settlements with 106 defendants totaling $34.3 million were announced as part of the same coordinated action.

The Health Care Fraud Unit (HCF Unit) of DOJ’s Criminal Division Fraud Section led all Fraud Section litigating units in 2025 on nearly every key metric:

194 individuals charged, 150 convicted at trial or by guilty plea
$15.02 billion in alleged individual losses — an all-time record
Four corporate enforcement actions — including the first corporate criminal healthcare indictments in nearly a decade

FY 2025 FCA recoveries reached $6.8 billion total, $5.7 billion from healthcare — the highest single-year total in the statute’s history, surpassing the prior record of $6.2 billion set in 2014. In FY 2023, total recoveries were $2.68 billion. In two years, they more than doubled.

Whistleblowers filed 1,297 qui tam lawsuits in FY 2025 — up 32% from the prior year’s record of 980. Those relators drove $5.3 billion in recoveries.

The Data Fusion Center: The Government Is Watching Billing in Real Time

The most consequential 2025 development for any healthcare provider or company was the launch of the Health Care Fraud Data Fusion Center — a multi-agency initiative combining DOJ, FBI, and HHS-OIG expertise in cloud computing, artificial intelligence, and real-time data analytics.

The impact is already documented. During the 2025 Takedown, DOJ’s Data Analytics Team detected anomalous billing through proactive analytics and prevented an organization from receiving all but approximately $41 million of the $4.45 billion that was scheduled to be paid by Medicare. The billing was flagged before most of it paid out.

The government is no longer waiting for complaints. It is watching billing data in real time. A federal healthcare fraud defense attorney who understands how the Data Fusion Center flags anomalies can help you assess your billing patterns against current enforcement benchmarks before you receive government notice.

DOJ’s Division for National Fraud Enforcement

On January 8, 2026, the White House announced the creation of the DOJ Division for National Fraud Enforcement — a structure designed to centralize and coordinate multi-district healthcare fraud investigations, with a dedicated Assistant Attorney General setting national enforcement priorities.

This is not a rebrand. It is a new organizational layer designed specifically to increase coordination, speed, and scale across investigations. If your billing patterns are flagged by the Data Fusion Center, this is the structure that decides whether the referral becomes a federal prosecution.

For any physician or healthcare company facing scrutiny today, the right question is not whether to engage a federal healthcare fraud defense attorney — it is how quickly. Every week of delay is a week the government spends building its case without your input.

Telemedicine Fraud: The Government’s Fastest-Growing Target

Telemedicine grew rapidly during the pandemic. DOJ’s enforcement capacity has now caught up. In 2026, telemedicine fraud is among the HCF Unit’s primary focus areas — and the enforcement risk extends well beyond obvious bad actors.

In the 2025 Takedown, 49 defendants were charged for telemedicine and genetic testing fraud involving $1.17 billion in alleged false claims to Medicare. The pattern DOJ targets: telemedicine orders signed without a legitimate physician-patient relationship, fraudulent DME claims, and genetic testing billed without clinical justification. If your telemedicine platform is under scrutiny, the right telemedicine fraud defense starts with understanding exactly what the government is looking for — and building the clinical record that rebuts it.

Operation Gold Rush

Inside the 2025 Takedown was a case that signals where enforcement is heading. Transnational criminal organizations allegedly used networks of foreign straw owners — placed physically inside the United States — who, acting on encrypted instructions from overseas, acquired dozens of American medical supply companies and submitted over $10.6 billion in fraudulent Medicare claims.

One defendant allegedly used AI-generated audio recordings to fabricate Medicare beneficiary consent, then sold beneficiaries’ confidential information to laboratories and DME companies that submitted false claims. The government seized approximately $44.7 million in related accounts.

What This Means for Legitimate Telemedicine Providers

The risk for properly licensed telemedicine platforms is less obvious but equally serious. The Data Fusion Center does not distinguish between criminal intent and billing anomalies. Volume outliers, orders lacking documented patient contact, and genetic tests billed without legitimate diagnosis codes all trigger the same algorithmic flags — regardless of actual intent.

What DOJ looks for in telemedicine fraud defense investigations:

Order volume exceeding regional norms relative to licensed providers on staff
Genetic testing or DME claims without documented clinical necessity
Patient acquisition through third-party marketing with high-volume, low-contact patterns
Physician oversight records insufficient to support the volume of orders signed

Your first line of defense is built before you are notified of an investigation: pattern of care documentation, physician oversight protocols, and clinical necessity records. A federal healthcare fraud defense attorney engaged before the subpoena arrives can assess whether your current documentation posture creates risk and help you address it proactively — before billing anomalies escalate to a CID.

Anti-Kickback Statute Enforcement: When a Business Arrangement Becomes a Federal Crime

The Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) is the foundation of most federal healthcare fraud prosecutions. It prohibits any remuneration offered, paid, solicited, or received to induce or reward referrals for services covered by federal healthcare programs. Intent is required — but courts and prosecutors interpret “willfully” broadly, and the standard does not require knowledge that the specific AKS provision was violated.

In practice: if money flows between parties with a referral relationship and federal program claims are involved, the government will examine whether the arrangement was designed to influence referral decisions.

2025 AKS Enforcement: What Actually Happened

Speaker programs. In April 2025, DOJ announced a $202 million civil FCA settlement with Gilead Sciences, of which $176.9 million was paid to the United States. The allegations: Gilead paid hundreds of practitioners honoraria, meals, and travel at speaker events to induce prescriptions of Gilead HIV drugs. Gilead made factual admissions. Speaker program enforcement is not abstract — it is a fully developed, well-resourced DOJ priority.

Medical directorships. January 2026 DOJ actions included a $34 million settlement with a home healthcare provider and a complaint against a hospital group for alleged medical directorship kickback arrangements in which fees paid to referring physicians were not supported by actual services rendered.

Clinical lab kickbacks. Multiple 2025 convictions addressed marketing services agreements disguised as consulting fees — compensation tied to referral volume, recharacterized as a legitimate business relationship. Several defendants received sentences of five to ten years.

Broker and enrollment incentives. DOJ intervened in qui tam actions against major national insurers for broker payment structures alleged to constitute kickbacks in exchange for Medicare Advantage enrollment.

Common AKS Risk Triggers

Medical directorship fees paid to physicians who also refer to your facility
Speaker program honoraria, particularly where high-volume prescribers are disproportionately selected
Marketing services agreements with labs where compensation reflects referral volume
Co-pay assistance programs structured around specific drug selection
Consulting arrangements with no documented deliverables

AKS safe harbors exist — employment, personal services, fair market value compensation — but they require strict structural compliance. The safe harbor does not protect you unless the arrangement is properly documented and satisfies each specific element. Whether you need an anti-kickback statute defense attorney for an existing investigation or a compliance review before one begins, early engagement with a federal healthcare fraud defense attorney who understands both the structure and the litigation risk is the only rational approach.

Stark Law: When Civil Violations Escalate to Criminal Prosecution

The Stark Law (42 U.S.C. § 1395nn) operates on a different standard. There is no intent requirement. If a physician refers patients for designated health services — laboratory, imaging, physical therapy, and others — to an entity in which the physician has a financial relationship, and no specific Stark exception applies, the referral violates the statute. The billing is false. FCA liability follows automatically.

This strict liability structure creates a trap for arrangements that appear commercially reasonable but are not properly documented under a recognized exception.

The Escalation Path: Civil to Criminal

Stark Law violations typically begin as compliance matters — internal audits, RAC reviews, CMS overpayment demands. They become criminal when:

The billing conduct also satisfies the intent elements of the AKS, exposing the physician to parallel criminal charges
False certifications on Medicare cost reports trigger FCA liability — treble damages and civil penalties up to $27,894 per false claim
A disgruntled former employee or business partner files a qui tam complaint under seal

The critical point about qui tam filings: once filed under seal, the government investigates before the defendant knows a complaint exists. By the time you receive notice, the government may have already reviewed two to three years of your billing records.

The 1,297 qui tam suits filed in FY 2025 are not abstract. Whistleblower-driven Stark and AKS matters account for the majority of FCA healthcare recoveries year after year. An experienced federal healthcare fraud defense attorney who handles Stark Law defense will identify whether an existing arrangement is exposed before a disgruntled former employee does it for you.

New Legal Terrain: Loper Bright and Jarkesy

Two Supreme Court decisions are reshaping Stark Law defense in ways still being litigated.

Loper Bright Enterprises v. Raimondo (2024) overturned the 40-year Chevron deference doctrine. Courts no longer defer to CMS’s interpretation of ambiguous regulatory provisions. Stark compliance often turns on the precise meaning of regulatory exceptions previously insulated from judicial review. Courts now independently interpret these provisions — creating new defense arguments while introducing unpredictability across circuits.

SEC v. Jarkesy (2024) raises constitutional questions about whether civil monetary penalties can be imposed in administrative proceedings without jury rights. Federal healthcare fraud statutes — including the AKS and Stark Law — rely heavily on administrative CMPs. This is an emerging argument that experienced Stark Law defense counsel is already raising in appropriate cases.

Military Healthcare, VA Contracts, and Tricare Fraud: Where Healthcare Fraud Meets Government Contracting

This is where most federal healthcare fraud defense firms reach the boundary of their experience — and where Watson & Associates’ background in both federal criminal defense and government contracting fraud defense provides a specific, concrete advantage.

TRICARE is the federal health benefit program for active duty military members, veterans, and their families. It is subject to the same AKS, Stark Law, and FCA enforcement framework as Medicare and Medicaid. Every clinical, billing, and compensation compliance risk applicable to Medicare applies equally to TRICARE.

VA healthcare contractors face an additional enforcement layer. Providers, staffing companies, and medical supply contractors working with the VA operate under both federal healthcare fraud statutes and government contracting fraud laws:

18 U.S.C. § 287 — false claims to the United States
18 U.S.C. § 1001 — false statements to federal agencies
FAR/DFARS — compliance certifications embedded in every VA and military health contract

Recent Enforcement Example

In February 2025, DOJ announced that Health Net Federal Services (HNFS) and parent company Centene Corporation agreed to pay $11.25 million to resolve FCA allegations. The basis: HNFS allegedly falsely certified cybersecurity compliance in its TRICARE administration contract with the Defense Health Agency from 2015 to 2018.

The lesson is not limited to cybersecurity. Any compliance certification embedded in a TRICARE or VA contract — clinical quality standards, staffing ratios, credentialing, billing accuracy representations — is a potential FCA trigger if the certification is false.

The Dual-Track Investigation Problem

A VA or military health contractor under DOJ investigation faces two concurrent enforcement tracks:

Federal healthcare fraud prosecution track — DOJ Criminal Division, HCF Unit, grand jury proceedings
Debarment and suspension track — the Suspension and Debarment Official can propose debarment independently of, and faster than, a criminal conviction

Most federal healthcare fraud defense firms handle track one. Without experience in government contracting fraud defense, they are unprepared for track two — and a debarment proposal while criminal proceedings are pending creates immediate financial exposure that a purely criminal defense strategy does not address. In a DOJ healthcare fraud investigation involving VA or TRICARE contracts, the debarment track can destroy a business faster than the criminal case resolves.

Who faces TRICARE and VA enforcement risk in 2026:

Pharmacy chains serving TRICARE beneficiaries
DME suppliers under military health contracts
Telemedicine platforms with VA or military health contracts
Clinical labs billing TRICARE through telemedicine referral channels
Healthcare staffing companies at military medical facilities
Any contractor making compliance certifications in VA or DoD contracts

A Tricare fraud defense attorney or VA healthcare fraud defense attorney with background in both criminal defense and government contracting law is not a niche specialty for edge cases. For this client population, it is a prerequisite.

What Happens When DOJ Targets You: The Investigation Timeline

Understanding how federal healthcare fraud investigations actually develop is essential to knowing when you must act — and how fast.

Investigations typically begin through one of five channels:

Data analytics flag — the Data Fusion Center or CMS claims processing identifies anomalous billing
Whistleblower complaint — a former employee, partner, or competitor files a qui tam complaint under seal
RAC/UPIC audit — a Recovery Audit Contractor or Unified Program Integrity Contractor initiates a review that escalates to OIG
OIG or CMS administrative subpoena — often the first overt signal
Search warrant — indicates a grand jury investigation is already advanced

The Escalation Path

Billing anomaly flagged by CMS data analytics
→ HHS-OIG opens administrative inquiry
→ OIG refers matter to DOJ Health Care Fraud Unit
→ Grand jury convened
→ Grand jury subpoena or Civil Investigative Demand (CID) issued
→ Document preservation obligation attaches immediately
→ Target letter issued → indictment likely unless defense intervenes
→ Indictment → arraignment → trial or resolution

The pre-charge phase is the most critical window. Clients who retain a federal healthcare fraud defense attorney at the CID or subpoena stage have measurably more strategic options than those who wait for indictment:

Grand jury strategy can be shaped before testimony is locked in
Document review and preservation can be coordinated with legal privilege
Early case assessment may identify dispositive defenses or mitigating facts the government has not yet developed
Civil resolution through DOJ Civil Division or CMS/OIG self-disclosure protocols may be available in lieu of criminal prosecution
Cooperation credit, where appropriate, is only available early — not after indictment

A critical data point from 2025: The HCF Unit brought four corporate enforcement actions, including two corporate criminal indictments — the first in nearly a decade. Entities, not just individuals, are now explicitly in the crosshairs. If you operate a medical group, a telemedicine platform, a billing company, or a government health contractor, your organization faces direct criminal exposure. Military healthcare fraud and VA contract fraud cases increasingly result in parallel corporate and individual charges.

Your Defense Framework: What Tends to Work

When DOJ opens a healthcare fraud investigation against your practice or organization, effective defense is not about technicalities. It is about building a specific, documented factual record that challenges the government’s theory at its weakest points.

Intent and Knowledge: The AKS Defense That Matters

The Anti-Kickback Statute requires proof that you knowingly and willfully paid or received remuneration to induce federal program referrals. “Willfully” does not require proof that you knew the specific statute you were violating — but the government must still prove criminal intent. A well-documented record of good faith compliance efforts, reliance on legal counsel opinions, and contemporaneous documentation of the legitimate business purpose behind compensation arrangements directly challenges proof of willfulness.

This is the central contested element in most AKS prosecutions — not a technicality.

Medical Necessity Documentation

False Claims Act healthcare fraud charges are most vulnerable to challenge through the clinical record. When the government alleges that services were medically unnecessary, the patient’s chart — if properly maintained — is your primary defense. Every test ordered, every consultation documented, every clinical decision recorded in the contemporaneous record becomes evidence that billing reflected genuine patient care.

If your documentation practices leave gaps, that is a compliance problem now and a defense problem later.

Compliance Program Evidence

A functioning, well-documented compliance program does not immunize a provider from prosecution. What it does is directly affect DOJ’s charging decisions and sentencing outcomes. DOJ’s guidance expressly directs prosecutors to evaluate whether a compliance program was genuine, well-resourced, and effectively implemented. A program with documented training, hotline activity, corrective action records, and annual risk assessments tells a materially different story than an empty compliance binder.

Self-Disclosure: When It Helps and When It Doesn’t

CMS and OIG both maintain voluntary self-disclosure protocols. When a Stark Law or AKS violation is discovered internally, the question of whether to self-disclose is one of the most consequential strategic decisions in healthcare compliance.

Arguments for early disclosure: reduced overpayment multiplier (often 1.5x rather than treble damages), reduced likelihood of exclusion, demonstrated good faith. Arguments against: disclosure accelerates the government’s investigation and may expand its scope.

This decision is not formulaic. An experienced federal healthcare fraud defense attorney will assess the specific facts, the likelihood that the conduct has already been detected, and the risk-adjusted value of each path before advising you.

The Early Engagement Principle

The data from 2025 is consistent with every prior enforcement cycle: those who engage experienced federal criminal defense counsel before indictment are positioned for better outcomes than those who wait. The window between the first overt government contact — a subpoena, a CID, an administrative inquiry — and indictment can close in months. In some cases, faster.

If you have received any formal government inquiry relating to billing practices, compensation arrangements, or contract compliance, treat it as a signal that the window is open — not as a routine administrative matter.

The Decision That Matters Most Is the One You Make Now

DOJ enters 2026 with its most powerful federal healthcare fraud enforcement infrastructure in history: a Data Fusion Center detecting billing anomalies before they pay out, a new Division for National Fraud Enforcement coordinating multi-district prosecutions, and 1,297 active whistleblower cases already moving through the system.

The physicians, executives, and healthcare company operators who navigate this environment successfully share one characteristic: they are not waiting to understand their exposure until after a subpoena arrives.

Watson & Associates defends federal healthcare fraud cases nationwide — including cases at the intersection of healthcare fraud, False Claims Act liability, and government contracting fraud that most law firms are not equipped to handle. If you are a TRICARE provider, a VA contractor, a telemedicine company with government health contracts, or a physician group facing a compensation arrangement review, the convergence of these enforcement tracks is not a hypothetical risk. It is where the 2026 enforcement calendar is pointing.

The earlier you consult a federal healthcare fraud defense attorney, the more options remain available. As a healthcare fraud defense lawyer, the question we hear most from clients who waited too long is simple: Why didn’t I call sooner? The answer is almost always the same: they assumed the inquiry was routine. It was not.

Call 1-866-601-5518 or contact Watson & Associates LLC online. The consultation is confidential. The window to act closes faster than most clients expect.